New treatments with myostatin inhibitors, thalidomide, selective COX-2 inhibitors, ghrelin mimetics and selective androgen receptor modulators have shown promising results, but their efficacy need to be confirmed in clinical trials that are at present testing multimodal interventions against cancer cachexia [5, 6]. Here, AR is linked to cancer.